<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="431">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05155540</url>
  </required_header>
  <id_info>
    <org_study_id>0201218</org_study_id>
    <nct_id>NCT05155540</nct_id>
  </id_info>
  <brief_title>Direct Mechanical Thrombectomy Versus Bridging Therapy</brief_title>
  <official_title>A Comparative Study of The Efficacy and Safety of Direct Mechanical Thrombectomy Versus Bridging Therapy in Large Vessel Occlusion: An Egyptian Single-Center Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging&#xD;
      therapy in patients with anterior circulation large vessel occlusion in a cohort of patients&#xD;
      treated at the stroke unit of a single centre at Alexandria University in Egypt.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open-label, non-randomized, prospective, double-arm clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Scale score</measure>
    <time_frame>3 months</time_frame>
    <description>A measurement of functional independence following ischemic stroke</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>within one week postoperatively</time_frame>
    <description>The rate and type of complications occuring postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The National Institutes of Health Stroke Scale (NIHSS) score</measure>
    <time_frame>at 24 hours postoperatively</time_frame>
    <description>A validated scale for assessment of neurological dysfunction associated with stroke</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Thrombectomy</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Large-Artery Atherosclerosis (Embolus/Thrombosis)</condition>
  <arm_group>
    <arm_group_label>Direct mechanical thrombectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Direct mechanical thrombectomy performed within 4.5 of stroke onset without giving intravenous recombinant tissue plasminogen activator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bridging therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trevo and or Merci devices for stent retreival</intervention_name>
    <description>FDA approved devices for stent retrieval during mechanical thrombectomy</description>
    <arm_group_label>Bridging therapy</arm_group_label>
    <arm_group_label>Direct mechanical thrombectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Penumbra system for stent aspiration</intervention_name>
    <description>FDA approved devices for stent aspiration during mechanical thrombectomy</description>
    <arm_group_label>Bridging therapy</arm_group_label>
    <arm_group_label>Direct mechanical thrombectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>recombinant tissue plasminogen activator</intervention_name>
    <description>FDA approved drug for treatment of acute ischemic stroke within 4.5 hours of strokeonset</description>
    <arm_group_label>Bridging therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with anterior ischemic stroke due to large vessel occlusion.&#xD;
&#xD;
          -  A previous autonomous modified Rankin Scale (mRS) of less than 2.&#xD;
&#xD;
          -  A National Institutes of Health Stroke Scale (NIHSS)â‰¥4&#xD;
&#xD;
          -  A groin puncture within 4.5 hours of the neurological deficit onset.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Imaging documentation of intracranial haemorrhage&#xD;
&#xD;
          -  A premorbid mRS score of 2 or more&#xD;
&#xD;
          -  Absence of diffusion perfusion mismatch in CT perfusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alexandria University Faculty of Medicine</name>
      <address>
        <city>Alexandria</city>
        <zip>11523</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 3, 2021</study_first_submitted>
  <study_first_submitted_qc>December 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>December 3, 2021</last_update_submitted>
  <last_update_submitted_qc>December 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Mohamed Anwar</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>Direct mechanical thrombectomy</keyword>
  <keyword>Bridging therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasminogen</mesh_term>
    <mesh_term>Tissue Plasminogen Activator</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The data will be available upon request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

